scholarly journals Skin Erosion

2020 ◽  
Author(s):  
Keyword(s):  
2017 ◽  
Vol 42 (videosuppl2) ◽  
pp. V2
Author(s):  
Paul House

The implantation of deep brain stimulator electrodes is associated with infrequent complications. These complications are consistent across prospective trials and include infection, skin erosion, hemorrhage, and lead misplacement. Nuances of surgical technique can be used to minimize the risk of these commonly noted complications. Several of these technical nuances are highlighted in this video submission.The video can be found here: https://youtu.be/GL09W9p013g.


2019 ◽  
Vol 16 (5) ◽  
pp. 1103-1111 ◽  
Author(s):  
Jing Gao ◽  
Liyun Wang ◽  
Chuankai Xia ◽  
Xingyu Yang ◽  
Zhicheng Cao ◽  
...  

2020 ◽  
pp. 125-128
Author(s):  
Ethan G. Brown ◽  
Monica Volz ◽  
Susan Heath ◽  
Nicholas B. Galifianakis ◽  
Jill L. Ostrem

Erosion of the skin overlying a deep brain stimulator (DBS) lead can occur in between 1 and 10% of cases. This complication increases the risk for subsequent infection, and full explantation of the lead is almost always necessary. In some specific cases, however, nonoperative management may be possible. This chapter describes a case of a patient with Parkinson disease (PD) and implantation of bilateral subthalamic nuclei (STN) DBS leads with a complicated postoperative course, requiring lead revision and extensive reprogramming to achieve therapeutic benefit. The patient later developed a skin erosion and eventual exposure of his brain lead, which recurred after skin graft placement. Because of the sterile appearance of his erosion and his willingness to be closely monitored, he was managed nonsurgically with only topical antibiotics. After 3 years of DBS therapy with an exposed lead, the erosion site became infected, requiring surgical movement of the system, but the patient experienced improved quality of life with DBS up until this point in time. Temporary nonoperative management of some low-infection-risk chronic lead erosions may be well-tolerated and allow for continued benefit from DBS. This conservative and controversial management choice may be helpful in rare cases in which a patient is benefiting greatly from DBS and would not be considered a candidate for DBS reimplantation.


2020 ◽  
pp. 089033442096514
Author(s):  
Josefine Theresia Maier ◽  
Julia Daut ◽  
Elisabeth Schalinski ◽  
Toni Fischer-Medert ◽  
Lars Hellmeyer

Introduction Puerperal mastitis, a complication occurring during the breastfeeding period, is often caused by Staphylococcus aureus. Here we report on severe streptococcal mastitis in a lactating breast, with subsequent invasive disease and wound healing problems. Main issue The 41-year-old woman (G2, P2) presented at 2 weeks postpartum to our hospital with painful swelling and reddening of the left breast, in addition to fever and malaise, and complained about a nipple fissure on the left breast. Previously, her 4-year-old son was treated for an acute otitis media and her husband experienced flu-like symptoms. Management Due to the severity of the symptoms, Clindamycin antibiotic treatment was initiated intravenously. Streptococcus pyogenes was isolated in the milk. This strain is commonly known to cause infections of the upper respiratory tract, skin, and soft tissue, but rarely mastitis. Furthermore, the participant developed invasive disease with abscess formation and skin erosion with a milk fistula. Special dressing was applied to promote wound healing. The participant continued breastfeeding well into the child’s 2nd year of life. Conclusion This rare form of complicated mastitis with invasive disease caused by Streptococcus pyogenes called for an interdisciplinary approach. We want to draw attention to other pathogens causing mastitis and to alert health care workers to promote hygiene in lactating women to prevent transmission.


2014 ◽  
Vol 42 (2) ◽  
pp. 225-226 ◽  
Author(s):  
Shinya Kitamura ◽  
Hiroaki Iwata ◽  
Keisuke Imafuku ◽  
Hiroo Hata ◽  
Ken Natsuga ◽  
...  

2020 ◽  
Vol 3 (2) ◽  
pp. V9
Author(s):  
Alba Scerrati ◽  
Pasquale De Bonis ◽  
Nicolò Norri ◽  
Michele Alessandro Cavallo

Most patients with spasticity, rigidity, and other symptoms of the upper motor neuron syndrome respond effectively to surgical treatment with an intrathecal baclofen pump when their symptoms become intractable to nonsurgical measures. Baclofen administered into the lumbar subarachnoid space produces a locally high concentration at the spinal level and a low concentration supraspinally, avoiding most of the central side effects associated with a high oral dose, such as drowsiness and confusion.The aim of surgical treatment is to provide the appropriate volume and concentration of the drug in the subarachnoid space, avoiding the main surgical complications, that is, infections, skin erosion, and catheter displacement.The video can be found here: https://youtu.be/HetelPwwwak


Sign in / Sign up

Export Citation Format

Share Document